rivaroxaban
bayer
['invictus', 'rivaroxaban', 'cardio']
contrary to expectations, vkas reduced the risk for ischemic stroke and death compared with the factor xa inhibitor rivaroxaban in patients with rheumatic heart disease and af, in the invictus trial. #esccongress #cardiotwitter 
theheartorg | Medscape Cardiology is your best source for cardiovascular disease news online. https://t.co/Q8t8IR82zV